/Mckesson%20Corporation%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
With a market cap of $74.3 billion, Irving, Texas-based McKesson Corporation (MCK) is a global healthcare services and information technology company. Operating through four key segments - U.S. Pharmaceutical; Prescription Technology Solutions (RxTS); Medical-Surgical Solutions; and International, it delivers comprehensive distribution, technology, and strategic solutions to enhance patient care and healthcare operations worldwide. MCK is expected to announce its fiscal Q3 earnings results after the market closes on Wednesday, Feb. 5.
Ahead of the event, analysts forecast the prescription drug distributor to post a profit of $8.28 per share, reflecting a growth of nearly 7% from $7.74 per share in the same quarter last year. The company has surpassed Wall Street's bottom-line projections in three of the past four quarters while missing on another occasion. MCK exceeded the consensus EPS estimate by a margin of 2.6% in the last reported quarter.